Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 614

1.

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.

Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M; D:A:D study group.

Eur J Prev Cardiol. 2015 Apr 16. pii: 2047487315579291. [Epub ahead of print]

PMID:
25882821
2.

How good are we at managing acute kidney injury in hospital?

Meran S, Wonnacott A, Amphlett B, Phillips A.

Clin Kidney J. 2014 Apr;7(2):144-50. doi: 10.1093/ckj/sfu010. Epub 2014 Feb 28.

3.

Rocket launcher: A novel reduction technique for posterior hip dislocations and review of current literature.

Dan M, Phillips A, Simonian M, Flannagan S.

Emerg Med Australas. 2015 Apr 6. doi: 10.1111/1742-6723.12392. [Epub ahead of print]

PMID:
25846901
4.

A qualitative study of smoking within a Western Sydney Arabic-speaking community: a focus on men in the context of their families.

Phillips A, Monaem A, Newman C.

Health Promot J Austr. 2015 Mar 24. doi: 10.1071/HE14030. [Epub ahead of print]

PMID:
25798526
5.

Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries.

Cambiano V, Ford D, Mabugu T, Napierala Mavedzenge S, Miners A, Mugurungi O, Nakagawa F, Revill P, Phillips A.

J Infect Dis. 2015 Mar 12. pii: jiv040. [Epub ahead of print]

PMID:
25767214
6.

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Soliman EZ, Sharma S, Arastéh K, Wohl D, Achhra A, Tambussi G, O'Connor J, Stein JH, Duprez DA, Neaton JD, Phillips A; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:46-54. doi: 10.1111/hiv.12233.

PMID:
25711323
7.

Self-management and transition among adolescents/young adults with chronic or end-stage kidney disease.

Ferris ME, Cuttance JR, Javalkar K, Cohen SE, Phillips A, Bickford K, Gibson K, Ferris MT, True K.

Blood Purif. 2015;39(1-3):99-104. doi: 10.1159/000368978. Epub 2015 Jan 20.

PMID:
25662749
8.

Variations in the cochlear implant experience in children with enlarged vestibular aqueduct.

Pritchett C, Zwolan T, Huq F, Phillips A, Parmar H, Ibrahim M, Thorne M, Telian S.

Laryngoscope. 2015 Feb 3. doi: 10.1002/lary.25187. [Epub ahead of print]

PMID:
25647353
9.

Bounds for the critical speed of climate-driven moving-habitat models.

Kot M, Phillips A.

Math Biosci. 2015 Apr;262:65-72. doi: 10.1016/j.mbs.2014.12.007. Epub 2015 Jan 30.

PMID:
25645183
10.

Warfarin cessation is non-essential in patients undergoing total knee arthroplasty-a case-control study.

Phillips A, Dan M, Schaefer N, Randle R.

J Orthop Surg Res. 2015 Jan 28;10(1):16. doi: 10.1186/s13018-015-0153-4.

11.

Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial.

Hajek P, McRobbie H, Myers Smith K, Phillips A, Cornwall D, Dhanji AR.

JAMA Intern Med. 2015 Feb;175(2):266-71. doi: 10.1001/jamainternmed.2014.6916.

PMID:
25545858
12.

The management of suspected scaphoid fractures in English hospitals: a national survey.

Smith JE, House RH, Gallagher J, Phillips A.

Eur J Emerg Med. 2014 Nov 27. [Epub ahead of print]

PMID:
25460813
13.

Incidence and attributable costs of ventilator-associated pneumonia (VAP) in a tertiary-level intensive care unit (ICU) in northern India.

Mathai AS, Phillips A, Kaur P, Isaac R.

J Infect Public Health. 2015 Mar-Apr;8(2):127-35. doi: 10.1016/j.jiph.2014.07.005. Epub 2014 Oct 28.

PMID:
25444392
14.

Securing the future of drug discovery for central nervous system disorders.

Andersen PH, Moscicki R, Sahakian B, Quirion R, Krishnan R, Race T, Phillips A; 2013 CINP Summit Group.

Nat Rev Drug Discov. 2014 Dec;13(12):871-2. doi: 10.1038/nrd4489.

PMID:
25435203
15.

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART.

Fidler S, Olson A, Fox J, Phillips A, Morrison C, Thornhill J, Bucher H, Muga R, Porter K.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19820. doi: 10.7448/IAS.17.4.19820. eCollection 2014.

16.

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK.

El Bouzidi K, White E, Mbisa JL, Phillips A, Mackie N, Pozniak A, Dunn D.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19739. doi: 10.7448/IAS.17.4.19739. eCollection 2014.

17.

Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death.

Fontdevila MC, Cozzi-Lepri A, Phillips A, Julian MN, Bickel M, Sedlacek D, Kronborg G, Lazzarin A, Zilmer K, Clotet B, Lundgren JD, Paredes R.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19685. doi: 10.7448/IAS.17.4.19685. eCollection 2014.

18.

Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study.

Daskalopoulou M, Rodger A, Thornton A, Phillips A, Sherr L, Gilson R, Johnson M, Fisher M, Anderson J, McDonnell J, Edwards S, Perry N, Collins S, Bhagani S, Speakman A, Smith C, Lampe F.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19630. doi: 10.7448/IAS.17.4.19630. eCollection 2014.

19.

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study.

Burch L, Smith C, Anderson J, Sherr L, Rodger A, O'Connell R, Gilson R, Elford J, Phillips A, Speakman A, Johnson M, Lampe F.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19533. doi: 10.7448/IAS.17.4.19533. eCollection 2014.

20.

Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study.

O'Connor J, Smith C, Lampe F, Johnson M, Sabin C, Phillips A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19527. doi: 10.7448/IAS.17.4.19527. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk